Van Gresham

Van Gresham

Van is a Partner, focusing on product development, change management, and product lifecycle management (PLM) strategy and implementation work in the life sciences, manufacturing and high tech industries.
  • Partner
  • (336) 456-7750

Prior to joining Kalypso, Van worked at RF Micro Devices (now Qorvo) and managed a team of employees chartered with developing and implementing processes and systems for engineering support. His focus was on maintaining RFMD’s new product introduction (NPI) process while leading a project focused on reducing their product development cycle time and defining measurable process metrics. Van also managed a team of cross-functional resources during the selection and implementation of PTC’s Windchill PLM solution.

Van holds a Bachelor of Science degree in Industrial and Systems Engineering from Virginia Tech. Since graduating from Virginia Tech, Van received certificates in Dale Carnegie’s leadership training program and the Graduate Program for Management Development from the University of North Carolina, Greensboro.

Current Projects

Since joining Kalypso, Van has served clients in the medical device, contract manufacturing, high tech and consumer packaged goods (CPG) industries. His main expertise is in product development related business processes and PLM strategy and implementations. Van has been a major factor in building Kalypso’s PTC practice, defining implementation methodologies and accelerators. Van has also been successful in supporting portfolio and pipeline management (PPM) implementations.

Outside of Kalypso

Van grew up in southwest Virginia and now lives in Oak Ridge, North Carolina with his wife and two children. Van spends his fall weekends attending Virginia Tech football games and thinks tailgating is a sport. He and his family enjoy boating and watersports during the summer months. Van and his family spend time each year raising money for Angels Among Us, a charitable organization at Duke University providing funding to help find a cure for brain tumors.